Target intelligence / Profile preview

Bacterial cell wall and fungal cell wall

Molecular classification
Other (Physical barrier / Structural component)
01

Overview

The bacterial cell wall is a rigid structure surrounding bacterial cells, primarily composed of peptidoglycan, which provides osmotic protection and defines cell shape. Gram-positive bacteria have thick peptidoglycan layers, often with teichoic acids, while Gram-negative bacteria have thinner peptidoglycan and an additional outer membrane. The fungal cell wall is a multilayered structure composed mainly of chitin, β-glucans, and glycoproteins, conferring rigidity, protection, and determining morphology. Both cell wall types are essential for microbial viability and are absent in mammalian cells, making their biosynthetic enzymes prime targets for antimicrobial drugs. Disruption of these walls leads to cell death, and various antibiotics and antifungal drugs act specifically by inhibiting the synthesis of their respective wall components[1][2][3][5][6].

Other names
bacterial cell wallfungal cell wallmicrobial cell wallcell wall (microbial)
02

Mechanism of action

Inhibition of peptidoglycan synthesis (bacteria: e.g., β-lactams); Inhibition of chitin or glucan synthesis (fungi: echinocandins inhibit β-1,3-glucan synthase); Disruption of cell wall structure and integrity, causing cell lysis

03

Biological functions

Structural integrityOsmotic protectionDetermination of cell shapeInteraction with host (immune recognition, adhesion)Barrier to environmental hazards
04

Disease associations

Infection (major role in pathogenesis of bacterial and fungal infections)Immune recognitionAntimicrobial resistance
05

Safety considerations

Off-target toxicity to mammalian cells is low due to absence of these cell wall structures in human cells; however, antibiotic resistance and fungal cell wall changes can reduce drug efficacy.Hypersensitivity reactions (some β-lactams)Effects on commensal flora (“dysbiosis”) for broad-spectrum agents
06

Interacting drugs

penicillins

8 more in the full profile.

07

Biomarkers

(1→3)-β-D-glucan (for fungal infections)Peptidoglycan components (experimental use)

Beyond the preview

Go deeper on Bacterial cell wall and fungal cell wall.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell wall and fungal cell wall.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call